Paul D Stein1, Fadi Matta1, Mary J Hughes1. 1. 1 Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, MI, USA.
Abstract
BACKGROUND: Management of patients with acute pulmonary embolism has evolved from obligatory hospitalization to home treatment of carefully selected low-risk patients. The purpose of this investigation is to determine national trends in the prevalence of home treatment of pulmonary embolism. METHODS: The Nationwide Emergency Department Sample was used to determine the number of patients seen in emergency departments throughout the United States with a primary (first-listed) diagnosis of pulmonary embolism and the proportion hospitalized according to age, from 2007 to 2012. The National (Nationwide) Inpatient Sample was used to determine in-hospital all-cause mortality and length of stay of hospitalized patients. Patients were adults (≥18 years) of both genders and all races from all regions of the United States. Excluded patients were those in shock or on ventilator support. International Classification of Diseases, Ninth Revision, Clinical Modification codes were used to identify patients and comorbid conditions. RESULTS: Home treatment was selected for 54 494 (6.0%) of 915 702 stable patients with acute pulmonary embolism. The proportion of patients treated at home was age-dependent, highest in those aged 30 years or younger, 12.1%, and lowest in those >80 years, 2.9%. Most patients treated at home, 66.8%, and had no comorbid conditions. In-hospital all-cause deaths were 2.6%. Deaths were ≤0.9% in those ≤40 years and 4.8% in those >80 years. Length of stay was 6 days or longer in 37.6% of patients. CONCLUSION: In view of the lower death rate among younger patients, they might be a group in whom home treatment would be more advantageous than in elderly patients.
BACKGROUND: Management of patients with acute pulmonary embolism has evolved from obligatory hospitalization to home treatment of carefully selected low-risk patients. The purpose of this investigation is to determine national trends in the prevalence of home treatment of pulmonary embolism. METHODS: The Nationwide Emergency Department Sample was used to determine the number of patients seen in emergency departments throughout the United States with a primary (first-listed) diagnosis of pulmonary embolism and the proportion hospitalized according to age, from 2007 to 2012. The National (Nationwide) Inpatient Sample was used to determine in-hospital all-cause mortality and length of stay of hospitalized patients. Patients were adults (≥18 years) of both genders and all races from all regions of the United States. Excluded patients were those in shock or on ventilator support. International Classification of Diseases, Ninth Revision, Clinical Modification codes were used to identify patients and comorbid conditions. RESULTS: Home treatment was selected for 54 494 (6.0%) of 915 702 stable patients with acute pulmonary embolism. The proportion of patients treated at home was age-dependent, highest in those aged 30 years or younger, 12.1%, and lowest in those >80 years, 2.9%. Most patients treated at home, 66.8%, and had no comorbid conditions. In-hospital all-cause deaths were 2.6%. Deaths were ≤0.9% in those ≤40 years and 4.8% in those >80 years. Length of stay was 6 days or longer in 37.6% of patients. CONCLUSION: In view of the lower death rate among younger patients, they might be a group in whom home treatment would be more advantageous than in elderly patients.
Entities:
Keywords:
home treatment; national trends; pulmonary embolism
Authors: Drahomir Aujesky; D Scott Obrosky; Roslyn A Stone; Thomas E Auble; Arnaud Perrier; Jacques Cornuz; Pierre-Marie Roy; Michael J Fine Journal: Arch Intern Med Date: 2006-01-23
Authors: S Siragusa; C Arcara; A Malato; R Anastasio; M R Valerio; F Fulfaro; L Lo Coco; S Grimaudo; G Bajardi; V Abbadessa; N Gebbia Journal: Ann Oncol Date: 2005-05 Impact factor: 32.976
Authors: Philip S Wells; David R Anderson; Marc A Rodger; Melissa A Forgie; Peggy Florack; Donna Touchie; Beverly Morrow; Lisa Gray; Keith O'Rourke; George Wells; Judy Kovacs; Michael J Kovacs Journal: Arch Intern Med Date: 2005-04-11
Authors: Drahomir Aujesky; D Scott Obrosky; Roslyn A Stone; Thomas E Auble; Arnaud Perrier; Jacques Cornuz; Pierre-Marie Roy; Michael J Fine Journal: Am J Respir Crit Care Med Date: 2005-07-14 Impact factor: 21.405
Authors: Pamela L Lutsey; Rob F Walker; Richard F MacLehose; Faye L Norby; Line H Evensen; Alvaro Alonso; Neil A Zakai Journal: J Am Heart Assoc Date: 2021-10-08 Impact factor: 5.501
Authors: Pierre-Marie Roy; Andrea Penaloza; Olivier Hugli; Frederikus A Klok; Armelle Arnoux; Antoine Elias; Francis Couturaud; Luc-Marie Joly; Raphaëlle Lopez; Laura M Faber; Marie Daoud-Elias; Benjamin Planquette; Jérôme Bokobza; Damien Viglino; Jeannot Schmidt; Henry Juchet; Isabelle Mahe; Frits Mulder; Magali Bartiaux; Rosen Cren; Thomas Moumneh; Isabelle Quere; Nicolas Falvo; Karine Montaclair; Delphine Douillet; Charlotte Steinier; Stephan V Hendriks; Ygal Benhamou; Tali-Anne Szwebel; Gilles Pernod; Nicolas Dublanchet; François-Xavier Lapebie; Nicolas Javaud; Alexandre Ghuysen; Mustapha Sebbane; Gilles Chatellier; Guy Meyer; David Jimenez; Menno V Huisman; Olivier Sanchez Journal: Eur Heart J Date: 2021-08-31 Impact factor: 29.983